Customer Center
Login | Register

Investor Relations

  • Banner Image

News Releases

Date Title  
Toggle Summary Luminex Corporation Reports Second Quarter 2019 Financial Results And Increase In Quarterly Dividend
AUSTIN, Texas , July 31, 2019 /PRNewswire/ --  Luminex Corporation (Nasdaq: LMNX) today announced financial results for the second quarter 2019. Financial and operating highlights for the quarter include: Second quarter consolidated revenue increased 4% to $83.1 million from $79.6 million in the
Toggle Summary Luminex Corporation Second Quarter Earnings Release Scheduled for July 31, 2019
AUSTIN, Texas , July 11, 2019 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that it plans to report results for the second quarter ended June 30, 2019 on Wednesday, July 31, 2019 . A press release announcing the results is scheduled for release after the close of trading on
Toggle Summary Luminex Submits ARIES MRSA Assay for FDA Clearance
AUSTIN, Texas , July 1, 2019 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) announced that the company submitted the ARIES® MRSA Assay to the U.S. Food and Drug Administration ( FDA ) for clearance on Friday, June 28, 2019 . The assay is a real-time, quantitative polymerase chain reaction
Toggle Summary Luminex Corporation Declares Second Quarter Cash Dividend
AUSTIN, Texas , May 21, 2019 /PRNewswire/ -- Luminex Corporation (Nasdaq:LMNX) (the "Company"), today announced that its board of directors declared a cash dividend for the second quarter of 2019 of $0.06 per share of common stock payable on July 11 , 2019 to stockholders of record as of the close
Toggle Summary Luminex Corporation to Present at Upcoming Healthcare Investor Conferences
AUSTIN, Texas , May 14, 2019 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that Homi Shamir , President and Chief Executive Officer, will participate in analyst-led fireside chats at the UBS Global Healthcare Conference to be held May 20, 2019 and at the Jefferies 2019 Global
Toggle Summary Luminex Corporation Reports First Quarter 2019 Financial Results
AUSTIN, Texas , May 6, 2019 /PRNewswire/ --  Luminex Corporation (NASDAQ:LMNX) today announced financial results for the first quarter 2019.  Financial and operating highlights for the quarter include: First quarter consolidated revenue of $82.4 million compared to the first quarter 2018 revenue of
Toggle Summary Luminex Corporation First Quarter Earnings Release Scheduled for May 6, 2019
AUSTIN, Texas , April 18, 2019 /PRNewswire/ --  Luminex Corporation (NASDAQ: LMNX) today announced that it plans to report results for the first quarter ended March 31, 2019 on Monday, May 6, 2019 . A press release announcing the results is scheduled for release after the close of trading on that
Toggle Summary Luminex Corporation to Present at the Barclays Global Healthcare Conference
AUSTIN, Texas , March 5, 2019 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that management will present at the Barclays Global Healthcare Conference to be held March 12-14, 2019 , in Miami . The fireside chat will begin at 9:30 a.m. Eastern time on Tuesday, March 12, 2019 .
Toggle Summary Luminex Corporation Declares First Quarter Cash Dividend
AUSTIN, Texas , Feb. 8, 2019 /PRNewswire/ --   Luminex Corporation (Nasdaq:LMNX) (the "Company"), today announced that its board of directors declared a cash dividend for the first quarter of 2019 of $0.06 per share of common stock payable on April 11 , 2019 to stockholders of record as of the
Toggle Summary Luminex Corporation Reports Fourth Quarter and Full-Year 2018 Financial Results
AUSTIN, Texas , Feb. 4, 2019 /PRNewswire/ --  Luminex Corporation (NASDAQ:LMNX) today announced financial results for the fourth quarter and full-year 2018.  Financial and operating highlights for the quarter and full-year include: On December 31, 2018 , the Company closed the acquisition of EMD